Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jonathan S. Berek, MD
Jonsson Comprehensive Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
46 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Center - Calgary
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- British Columbia Cancer Agency - Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
- British Columbia Cancer Agency
Vancouver, British Columbia, Canada
- Manitoba Cancer Treatment and Research Foundation
Winnipeg, Manitoba, Canada
- Saint John Regional Hospital
Saint John, New Brunswick, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Northeastern Ontario Regional Cancer Centre, Sudbury
Greater Sudbury, Ontario, Canada
- Cancer Care Ontario-Hamilton Regional Cancer Centre
Hamilton, Ontario, Canada
- Cancer Care Ontario-London Regional Cancer Centre
London, Ontario, Canada
- Credit Valley Hospital
Mississauga, Ontario, Canada
- Ottawa Regional Cancer Center - General Division
Ottawa, Ontario, Canada
- Toronto Sunnybrook Regional Cancer Centre
Toronto, Ontario, Canada
- Centre Universitaire de Sante de L'Estrie
Fleurimont, Quebec, Canada
- Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Jewish General Hospital - Montreal
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Quebec, Pavillion de Quebec
Québec, Quebec, Canada
- Alta Bates Comprehensive Cancer Center
Berkeley, California, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
- Chao Family Comprehensive Cancer Center
Orange, California, United States
- Wilshire Oncology Medical Center
Pomona, California, United States
- Stanford University School of Medicine
Stanford, California, United States
- University of Colorado Cancer Center
Denver, Colorado, United States
- Patty Berg Cancer Center
Fort Myers, Florida, United States
- University of Florida Health Science Center - Jacksonville
Jacksonville, Florida, United States
- Walt Disney Memorial Cancer Institute
Orlando, Florida, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Saint Mary'S Hospital
East Saint Louis, Illinois, United States
- Lutheran General Cancer Care Center
Park Ridge, Illinois, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Alton Ochsner Medical Foundation Hospital
New Orleans, Louisiana, United States
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland
Baltimore, Maryland, United States
- New England Medical Center Hospital
Boston, Massachusetts, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- University of Minnesota Medical School
Minneapolis, Minnesota, United States
- Ellis Fischel Cancer Center
Columbia, Missouri, United States
- North Shore University Hospital
Manhasset, New York, United States
- State University of New York - Upstate Medical University
Syracuse, New York, United States
- University of Oklahoma
Oklahoma City, Oklahoma, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 1998
- Primary completion
- —
- Completion
- —
- Last update posted
- 6 Nov 2013
- Registered enrollment
- 400
- Registry id
- NCT00003634
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.